- Home
- PFIS vs INBX Comparison
PFIS vs INBX Comparison
Compare PFIS & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PFIS | INBX |
|---|---|---|
| Founded | 1905 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 495.3M | 430.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PFIS | INBX |
|---|---|---|
| Price | $48.50 | $76.65 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.2K | ★ 254.4K |
| Earning Date | 02-05-2026 | 11-14-2025 |
| Dividend Yield | ★ 5.07% | N/A |
| EPS Growth | ★ 582.67 | N/A |
| EPS | ★ 5.29 | N/A |
| Revenue | ★ $182,622,000.00 | $1,400,000.00 |
| Revenue This Year | $68.41 | $563.00 |
| Revenue Next Year | $4.87 | N/A |
| P/E Ratio | $9.21 | ★ N/A |
| Revenue Growth | ★ 89.84 | N/A |
| 52 Week Low | $38.90 | $10.81 |
| 52 Week High | $54.20 | $94.57 |
Technical Indicators
Market Signals| Indicator | PFIS | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 44.93 |
| Support Level | $47.89 | $74.46 |
| Resistance Level | $49.67 | $82.34 |
| Average True Range (ATR) | 1.31 | 5.85 |
| MACD | -0.43 | -1.32 |
| Stochastic Oscillator | 10.33 | 8.75 |
Price Performance
Historical ComparisonAbout PFIS Peoples Financial Services Corp.
Peoples Financial Services Corp is a bank holding company operating through its subsidiaries. The bank provides a full range of financial services. Its products and services include checking accounts, business accounts, savings accounts, loan products, money market accounts, mortgages, chip-enabled debit cards, credit card processing, and visa master card and advisory services. Its loan portfolio includes Commercial loans, which consist of commercial, commercial real estate, municipal, and other related tax-free loans; and retail loans, which include residential real estate and other consumer loans. The company mainly operates in the United States in Pennsylvania.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.